Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 4
2018 21
2019 25
2020 55
2021 50
2022 30
2023 28
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
Breast cancer treatment: A phased approach to implementation.
Mutebi M, Anderson BO, Duggan C, Adebamowo C, Agarwal G, Ali Z, Bird P, Bourque JM, DeBoer R, Gebrim LH, Masetti R, Masood S, Menon M, Nakigudde G, Ng'ang'a A, Niyonzima N, Rositch AF, Unger-Saldaña K, Villarreal-Garza C, Dvaladze A, El Saghir NS, Gralow JR, Eniu A. Mutebi M, et al. Cancer. 2020 May 15;126 Suppl 10:2365-2378. doi: 10.1002/cncr.32910. Cancer. 2020. PMID: 32348571 Free article. Review.
Breast cancer early detection: A phased approach to implementation.
Ginsburg O, Yip CH, Brooks A, Cabanes A, Caleffi M, Dunstan Yataco JA, Gyawali B, McCormack V, McLaughlin de Anderson M, Mehrotra R, Mohar A, Murillo R, Pace LE, Paskett ED, Romanoff A, Rositch AF, Scheel JR, Schneidman M, Unger-Saldaña K, Vanderpuye V, Wu TY, Yuma S, Dvaladze A, Duggan C, Anderson BO. Ginsburg O, et al. Cancer. 2020 May 15;126 Suppl 10(Suppl 10):2379-2393. doi: 10.1002/cncr.32887. Cancer. 2020. PMID: 32348566 Free PMC article.
An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy.
Khalil BD, Sanchez R, Rahman T, Rodriguez-Tirado C, Moritsch S, Martinez AR, Miles B, Farias E, Mezei M, Nobre AR, Singh D, Kale N, Sproll KC, Sosa MS, Aguirre-Ghiso JA. Khalil BD, et al. J Exp Med. 2022 Jan 3;219(1):e20210836. doi: 10.1084/jem.20210836. Epub 2021 Nov 23. J Exp Med. 2022. PMID: 34812843 Free PMC article.
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer.
Carter JM, Chumsri S, Hinerfeld DA, Ma Y, Wang X, Zahrieh D, Hillman DW, Tenner KS, Kachergus JM, Brauer HA, Warren SE, Henderson D, Shi J, Liu Y, Joensuu H, Lindman H, Leon-Ferre RA, Boughey JC, Liu MC, Ingle JN, Kalari KR, Couch FJ, Knutson KL, Goetz MP, Perez EA, Thompson EA. Carter JM, et al. Nat Commun. 2023 Apr 18;14(1):2215. doi: 10.1038/s41467-023-37806-0. Nat Commun. 2023. PMID: 37072398 Free PMC article.
Clinical Implications of Extracellular HMGA1 in Breast Cancer.
Méndez O, Pérez J, Soberino J, Racca F, Cortés J, Villanueva J. Méndez O, et al. Int J Mol Sci. 2019 Nov 26;20(23):5950. doi: 10.3390/ijms20235950. Int J Mol Sci. 2019. PMID: 31779212 Free PMC article. Review.
How much do we know about the metastatic process?
Rodriguez-Tirado C, Sosa MS. Rodriguez-Tirado C, et al. Clin Exp Metastasis. 2024 Mar 23. doi: 10.1007/s10585-023-10248-0. Online ahead of print. Clin Exp Metastasis. 2024. PMID: 38520475 Review.
207 results